Hippocampal dysregulation of dopamine system activity as a pathophysiological basis for psychosis in schizophrenia

Clinical Psychopharmacology and Neuroscience

Volumn 8, Issue 1, 2010, Pages 1-9

  Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Burst firing; Development; Dopamine hippocampus; Gamma oscillations; Glutamate; Nucleus accumbens; Schizophrenia; Subiculum; Ventral tegmental area

Indexed keywords

DOPAMINE;

BEHAVIOR; BRAIN CORTEX; DISEASE COURSE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; STIMULUS RESPONSE; VENTRAL TEGMENTUM;

EID: 77952041323     PISSN: 17381088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Wu EQ, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, et al. The economic burden of schizophrenia in the United States in 2002. J Clin Psychiatry 2005;66:1122-1129.
2. Carlsson A, Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol (Copenh) 1963;20:140-144.
3. Seeman P, Lee T, Chau-Wong M, Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 1976;261:717-719.
4. Creese I, Burt DR, Snyder SH. Dopamine receptor binding predicts clinical and pharmacological potencies of anti-schizophrenic drugs. Science 1976;192:481-483.
5. Angrist B, Sathananthan G, Wilk S, Gershon S. Amphetamine psychosis: behavioral and biochemical aspects. J Psychiatr Res 1974;11:13-23.
6. Friedman A, Sienkiewicz J. Psychotic complications of long-term levodopa treatment of Parkinson's disease. Acta Neurol Scand 1991;84:111-113.
7. Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. J Neural Transm 2000;107:59-71. (Pubitemid 30077043)
8. Angrist B, Thompson H, Shopsin B, Gershon S. Clinical studies with dopamine-receptor stimulants. Psychopharmacologia 1975;44:273-280.
9. van Rossum JM. The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs. Arch Int Pharmacodyn Ther 1966;160:492-494.
10. Hollister LE, Krieger GE, Kringel A, Roberts RH. Treatment of chronic schizophrenic reactions with reserpine. Ann N Y Acad Sci 1955;61:92-100.
11. Beuger M, van Kammen DP, Kelley ME, Yao J. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies. Neuropsychopharmacology 1996;15:75-86.
12. Post RM, Fink E, Carpenter WT Jr, Goodwin FK. Cerebrospinal fluid amine metabolites in acute schizophrenia. Arch Gen Psychiatry 1975;32:1063-1069.
13. van Kammen DP, van Kammen WB, Mann LS, Seppala T, Linnoila M. Dopamine metabolism in the cerebrospinal fluid of drug-free schizophrenic patients with and without cortical atrophy. Arch Gen Psychiatry 1986;43:978-983.
14. Sharp T, Zetterström T, Ljungberg T, Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 1987;401:322-330. (Pubitemid 17221822)
15. Johnstone EC, Crow TJ, Frith CD, Carney MW, Price JS. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet 1978;22:848-851. (Pubitemid 8321793)
16. Agid O, Kapur S, Arenovich T, Zipursky RB. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry 2003;60:1228-1235.
17. Shoptaw SJ, Kao U, Ling W. Treatment for amphetamine psychosis. Cochrane Database Syst Rev 2009;(1):CD003026.
18. Lamelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 1999;46:56-72. (Pubitemid 29296818)
19. Grace AA. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev 2000;31:330-341.
20. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991;148:1301-1308.
21. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF. Model psychoses and schizophrenia. Am J Psychiatry 1962;119:61-67.
22. Weinberger DR, Berman KF, Zec RF. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. Arch Gen Psychiatry 1986;43:114-124.
23. Berman KF, Zec RF, Weinberger DR. Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort. Arch Gen Psychiatry 1986;43:126-135.
24. Kovelman JA, Scheibel AB. A neurohistological correlate of schizophrenia. Biol Psychiatry 1984;19:1601-1621.
25. Conrad AJ, Abebe T, Austin R, Forsythe S, Scheibel AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991;48:413-417.
26. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med 1990;322:789-794. (Pubitemid 20094141)
27. Lee AL, Ogle WO, Sapolsky RM. Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord 2002;4:117-128.
28. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci 1990;10:2897-2902.
29. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000;57:925-935.
30. Benes FM. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiatr Res 1997;31:257-275.
31. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 1996;53:25-31.
32. McDonald C, Murray RM. Early and late environmental risk factors for schizophrenia. Brain Res Brain Res Rev 2000;31:130-137.
33. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993;9:67-75.
34. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology (Berl) 1995;122:35-43.
35. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 2002;27:47-54.
36. Gottesman II. Schizophrenia genesis: The origins of madness. New York:Freeman;1991.
37. Grace AA, Moore H. Regulation of information flow in the nucleus accumbens: a model for the pathophysiology of schizophrenia. In: Lenzenweger MF, Dworkin RH, editors. Origins and development of schizophrenia: advances in experimental psychopathology. Washington DC: American Psychological Association Press;1998. p.123-157.
38. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 2006;60:253-264. (Pubitemid 44093447)
39. Pilowsky LS, Kerwin RW, Murray RM. Schizophrenia: a neurodevelopmental perspective. Neuropsychopharmacology 1993;9:83-91.
40. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999;122:593-624.
41. Moore H, Grace AA. Anatomical changes in limbic structures produced by methylazoxymethanol acetate (MAM) during brain development are associated with changes in physiological interactions among afferents to the nucleus accumbens. Soc Neurosci Abstr 1997;23:2378.
42. Flagstad P, Mørk A, Glenthøj BY, van Beek J, Michael-Titus AT, Didriksen M. Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsychopharmacology 2004;29:2052-2064. (Pubitemid 39486557)
43. Gourevitch R, Rocher C, Le Pen G, Krebs MO, Jay TM. Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 2004;15:287-292. (Pubitemid 39062558)
44. Le Pen G, Gourevitch R, Hazane F, Hoareau C, Jay TM, Krebs MO. Peri-pubertal maturation after developmental disturbance: a model for psychosis onset in the rat. Neuroscience 2006;143:395-405. (Pubitemid 44781063)
45. Lodge DJ, Behrens MM, Grace AA. A reduction in hippocampal and prefrontal cortical gamma oscillatory activity is associated with a decrease in parvalbumin interneurons in the mam model of schizophrenia. Society for Neuroscience, Neuroscience Meeting Planner, Program No 657.2, Washington DC, 2008.
46. Talamini LM, Koch T, Luiten PG, Koolhaas JM, Korf J. Interruptions of early cortical development affect limbic association areas and social behaviour in rats; possible relevance for neurodevelopmental disorders. Brain Res 1999;847:105-120. (Pubitemid 29516711)
47. Fiore M, Grace AA, Korf J, Stampachiacchiere B, Aloe L. Impaired brain development in the rat following prenatal exposure to methylazoxymethanol acetate at gestational day 17 and neurotrophin distribution. Neuroreport 2004;15:1791-1795. (Pubitemid 39062596)
48. Malaspina D, Storer S, Furman V, Esser P, Printz D, Berman A, et al. SPECT study of visual fixation in schizophrenia and comparison subjects. Biol Psychiatry 1999;46:89-93. (Pubitemid 29296821)
49. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001;11:520-528.
50. Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, et al. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res 2000;98:163-175.
51. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus 2001;11:543-550.
52. Meyer-Lindenberg AS, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, et al. Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. Arch Gen Psychiatry 2005;62:379-386. (Pubitemid 40471687)
53. Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology 2006;31:221-230.
54. Weiss AP, Goff D, Schacter DL, Ditman T, Freudenreich O, Henderson D, et al. Fronto-hippocampal function during temporal context monitoring in schizophrenia. Biol Psychiatry 2006;60:1268-1277. (Pubitemid 44693542)
55. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378:176-179.
56. Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 1995;6:869-872.
57. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: single spike firing. J Neurosci 1984;4:2866-2876. (Pubitemid 15224431)
58. Grace AA, Bunney BS. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Res 1985;333:271-284.
59. Floresco SB, Todd CL, Grace AA. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 2001;21:4915-4922.
60. Floresco SB, West AR, Ash B, Moore H, Grace AA. Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 2003;6:968-973. (Pubitemid 37064759)
61. Schultz W. The phasic reward signal of primate dopamine neurons. Adv Pharmacol 1998;42:686-690. (Pubitemid 28326237)
62. Grace AA, Bunney BS. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 1984;4:2877-2890. (Pubitemid 15224432)
63. Lodge DJ, Grace AA. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 2006;31:1356-1361. (Pubitemid 43910431)
64. Mayer ML, Westbrook GL, Guthrie PB. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones. Nature 1984;309:261-263.
65. Jarrard LE. What does the hippocampus really do? Behav Brain Res 1995;71:1-10.
66. Maren S. Neurotoxic or electrolytic lesions of the ventral subiculum produce deficits in the acquisition and expression of Pavlovian fear conditioning in rats. Behav Neurosci 1999;113:283-290. (Pubitemid 29230937)
67. Sharp PE. Complimentary roles for hippocampal versus subicular/entorhinal place cells in coding place, context, and events. Hippocampus 1999;9:432-443.
68. Fanselow MS. Contextual fear, gestalt memories and the hippocampus. Behav Brain Res 2000;110:73-81. (Pubitemid 30236293)
69. Lodge DJ, Grace AA. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci 2007;27:11424-11430.
70. Lamelle M, Abi-Dargham A. Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 1999;13:358-371. (Pubitemid 30055180)
71. Lamelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 1996;93:9235-9240. (Pubitemid 26282047)
72. Zhang ZJ, Reynolds GP. A selective decrease in the relative density of parvalbumin-immunoreactive neurons in the hippocampus in schizophrenia. Schizophr Res 2002;55:1-10. (Pubitemid 34310531)
73. Lewis DA, Cruz DA, Melchitzky DS, Pierri JN. Laminaspecific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am J Psychiatry 2001;158:1411-1422.
74. Vida I, Bartos M, Jonas P. Shunting inhibition improves robustness of gamma oscillations in hippocampal interneuron networks by homogenizing firing rates. Neuron 2006;49:107-117.
75. Bartos M, Vida I, Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nat Rev Neurosci 2007;8:45-56. (Pubitemid 46011998)
76. Fuchs EC, Zivkovic AR, Cunningham MO, Middleton S, Lebeau FE, Bannerman DM, et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 2007;53:591-604. (Pubitemid 46216760)
77. Tukker JJ, Fuentealba P, Hartwich K, Somogyi P, Klausberger T. Cell type-specific tuning of hippocampal interneuron firing during gamma oscillations in vivo. J Neurosci 2007;27:8184-8189. (Pubitemid 47219603)
78. Buzsáki G, Draguhn A. Neuronal oscillations in cortical networks. Science 2004;304:1926-1929.
79. González-Hernández JA, Cedeño I, Pita-Alcorta C, Galán L, Aubert E, Figueredo-Rodríguez P. Induced oscillations and the distributed cortical sources during the Wisconsin card sorting test performance in schizophrenic patients: new clues to neural connectivity. Int J Psychophysiol 2003;48:11-24. (Pubitemid 36407682)
80. Gallinat J, Winterer G, Herrmann CS, Senkowski D. Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing. Clin Neurophysiol 2004;115:1863-1874. (Pubitemid 38952954)
81. Cho RY, Konecky RO, Carter CS. Impairments in gamma band synchronization and context processing in schizophrenia. Schizophr Bull 2005;31:450-451.
82. Basar-Eroglu C, Brand A, Hildebrandt H, Karolina Kedzior K, Mathes B, Schmiedt C. Working memory related gamma oscillations in schizophrenia patients. Int J Psychophysiol 2007;64:39-45. (Pubitemid 46483768)
83. Lodge DJ, Behrens MM, Grace AA. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 2009;29:2344-2354.
84. Jones RS, Bühl EH. Basket-like interneurones in layer II of the entorhinal cortex exhibit a powerful NMDA-mediated synaptic excitation. Neurosci Lett 1993;149:35-39.
85. Buhl EH, Szilágyi T, Halasy K, Somogyi P. Physiological properties of anatomically identified basket and bistratified cells in the CA1 area of the rat hippocampus in vitro. Hippocampus 1996;6:294-305. (Pubitemid 26275789)